News

19 May 2019

4Dx Presents First Human Scan Data From XV Technology Clinical Trials

Andreas Fouras, PhD, (founder and CEO of 4Dx) presented this week the first release of the highly anticipated results from 4Dx’s clinical trials at the American Thoracic Society (ATS) 2019 International Conference in Dallas, TX, 4Dx opened Day 1 of the 3-day conference with a newly-designed booth dedicated to showcasing the first of many 4-dimensional […]

READ POST
26 Apr 2019

FUNDING FOR GROUND-BREAKING LUNG DIAGNOSTIC TECHNOLOGY

 The Hon. Greg Hunt MP  Minister for Health  MEDIA RELEASE  FUNDING FOR GROUND-BREAKING LUNG DIAGNOSTIC TECHNOLOGY  The Liberal National Government will provide $960,000 for intensive research into new 4D diagnostic technology to allow accurate assessment of lung function in patients of all ages including the very sick.  The Australian Lung Health Initiative headed by Professor […]

READ POST
23 Nov 2018

Wind Tunnel Technology Fights Lung Disease

Headquartered in Westlake Village, CA, 4DX developed a medical technology that has the capacity to simply, safely, and effectively view lung air flow function in fine detail.   Andreas Fouras, CEO of 4DX, and a mechanical engineer by training, is behind this innovation. While working at a major university in Australia in wind tunnel research, […]

READ POST
10 Sep 2018

Radiology Today Magazine: More With Less

Advanced software reduces dose without sacrificing image quality.   Although the direct health risk of medical diagnostic scanning is not unequivocally clear, it is important for patients as well as health care professionals to mitigate the risks of radiation dose. While most of the concern regarding overexposure and cumulative dose has historically been focused on […]

READ POST
24 Aug 2018

MD+DI Online Interview: An Australian Startup’s Unique Approach to Imaging Lung Function

4Dx has developed an algorithm-based software that converts X-ray images into more detailed airflow studies. 4Dx is developing a software-as-a-service technology that enables four-dimensional lung imaging tests using the imaging equipment already in place at hospitals and other clinical settings. The company expects to have FDA clearance for the software sometime in 2019. Here’s a […]

READ POST
07 Aug 2018

Medical imaging startup takes new approach to viewing lung disease

The company’s algorithms use existing fluoroscopy technology, which captures structures in motion and is commonly used to image the cardiovascular system or direct invasive procedures.   Lung diseases, like asthma, cystic fibrosis (CF) and COPD, affect millions of people worldwide. However, current diagnostics don’t necessarily provide enough data to support the best possible care. Spirometry […]

READ POST
03 Jul 2018

Seeing Asthma Differently with the 4Dx Scanner. Targeting specific airways instead of overall airflow

  Cleveland Clinic Lerner Research Institute was recently awarded funding from the National Institutes of Health (NIH) to purchase a leading-edge preclinical scanner from 4Dx Limited, a Melbourne-based medical technology company, to investigate the causes and treatment of asthma. Cleveland Clinic becomes only the second institution in the world to own a 4Dx preclinical scanner (joining […]

READ POST
25 Jun 2018

4Dx 2017 Retail Investment Round Closing 28 June

4Dx Limited is pleased to announce that our retail fundraising offer, under our Offer Information Statement disclosure document dated 20 October 2017, will be closing on 28 June 2018, fully subscribed.  We are currently taking oversubscriptions and the offer remains open to all Australian residents.  Please visit: http://invest.4dx.com/ to access our online application portal. Existing shareholders […]

READ POST
24 Jun 2018

Australian National Imaging Facility (NIF) to Establish 4Dx Research Eco-system in Adelaide

4Dx is pleased to announce that following increased Federal Government budget to the National Imaging Facility (NIF), a 4Dx technology translational research eco-system will be established in Adelaide. Operating out of the SAHMRI LARIF Node of NIF location, collaborators will be able use 4Dx technology on mice, sheep, pigs and in clinical research studies, in a turn-key operation. […]

READ POST
23 Jun 2018

2018 American Thoracic Society (ATS) Conference

4Dx attended this year’s American Thoracic Society (ATS) Conference held May 18-23 in San Diego. ATS represented a unique opportunity to launch 4Dx Group brands to industry and communicate our unique offering to Physicians and Researchers.  It also facilitated dialogue with the pharmaceutical industry.  Our core conference objectives were to solicit interest in Top 50 […]

READ POST